-
-
-
-
-
-
-
Niagen Bioscience adds advisors for drug development push
-
-
-
-
-
-
-
Palvella Therapeutics receives Yale-licensed patent for QTORIN pitavastatin
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $240 at Chardan
-
-
-
-
-
-
-
Palvella receives European patent for QTORIN rapamycin formulation
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $250 at Stifel
-
-
-
-
-
-
-
TD Cowen on Palvella Therapeutics' (PVLA) SELVA Data Preview: 'High Conviction for Success'
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $190 at Truist Securities
-
481,371 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


